Vitamin D as a resilience factor, helpful for survival of potentially fatal conditions: A hypothesis emerging from recent findings of the ESTHER cohort study and the CHANCES consortium

Nutrients

Volumn 7, Issue 5, 2015, Pages 3264-3278

  Schöttker, Ben ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer; Cardiovascular disease; Death; Mortality; Review; Vitamin D

Indexed keywords

VITAMIN D;

CANCER INCIDENCE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DIETARY INTAKE; IMMUNE SYSTEM; INTERNAL CONSISTENCY; NEOPLASM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SUN EXPOSURE; SYSTEMATIC REVIEW (TOPIC); ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; BLOOD; COMPLICATION; EUROPE; HUMAN; MORTALITY; PROTECTION; UNITED STATES;

CARDIOVASCULAR DISEASES; EUROPE; HUMANS; NEOPLASMS; PROTECTIVE FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84929346574     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7053264     Document Type: Review

References (72)

1. Macdonald, H. M.; Mavroeidi, A.; Fraser, W. D.; Darling, A. L.; Black, A. J.; Aucott, L.; O'Neill, F.; Hart, K.; Berry, J. L.; Lanham-New, S. A.; et al. Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: A major cause for concern? Osteoporos. Int. 2011, 22, 2461-2472.
2. Blunt, J. W.; DeLuca, H. F.; Schnoes, H. K. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry 1968, 7, 3317-3322.
3. Fraser, D. R.; Kodicek, E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970, 228, 764-766.
4. Zerwekh, J. E. Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 2008, 87, 1087S-1091S.
5. Brown, A. J.; Dusso, A.; Slatopolsky, E. Vitamin D. Am. J. Physiol. 1999, 277, 157-175.
6. Veldman, C. M.; Cantorna, M. T.; de Luca, H. F. Expression of 1, 25-dihydroxyvitamin D3 receptor in the immune system. Arch. Biochem. Biophys. 2000, 374, 334-338.
7. Chen, S.; Glenn, D. J.; Ni, W.; Grigsby, C. L.; Olsen, K.; Nishimoto, M.; Law, C. S.; Gardner, D. G. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 2008, 52, 1106-1112.
8. Holick, M. F. Evolution and function of vitamin D. Recent Results Cancer Res. 2003, 164, 3-28.
9. Murad, M. H.; Elamin, K. B.; Abu Elnour, N. O.; Elamin, M. B.; Alkatib, A. A.; Fatourechi, M. M.; Almandoz, J. P.; Mullan, R. J.; Lane, M. A.; Liu, H.; et al. The effect of vitamin D on falls: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96, 2997-3006.
10. Bischoff-Ferrari, H. A.; Willett, W. C.; Wong, J. B.; Giovannucci, E.; Dietrich, T.; Dawson-Hughes, B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005, 293, 2257-2264.
11. Wang, L.; Song, Y.; Manson, J. E.; Pilz, S.; Marz, W.; Michaelsson, K.; Lundqvist, A.; Jassal, S. K.; Barrett-Connor, E.; Zhang, C.; et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 819-829.
12. Song, Y.; Wang, L.; Pittas, A. G.; Del Gobbo, L. C.; Zhang, C.; Manson, J. E.; Hu, F. B. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 2013, 36, 1422-1428.
13. Moukayed, M.; Grant, W. B. Molecular link between vitamin D and cancer prevention. Nutrients 2013, 5, 3993-4021.
14. Watkins, R. R.; Lemonovich, T. L.; Salata, R. A. An update on the association of vitamin D deficiency with common infectious diseases. Can. J. Physiol. Pharmacol. 2015, doi: 10. 1139/cjpp-2014-0352.
15. Delvin, E.; Souberbielle, J. C.; Viard, J. P.; Salle, B. Role of vitamin D in acquired immune and autoimmune diseases. Crit. Rev. Clin. Lab. Sci. 2014, 51, 232-247.
16. World Health Organization. The Top 10 Causes of Death. Fact Sheet No. 310. 2014. Available online: http://www. who. int/mediacentre/factsheets/fs310/en/(accessed on March 3 2015).
17. Perna, L.; Schöttker, B.; Holleczek, B.; Brenner, H. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: A prospective study with repeated measurements. J. Clin. Endocrinol. Metab. 2013, 98, 4908-4915.
18. Ordóñez-Mena, J. M.; Schöttker, B.; Haug, U.; Müller, H.; Köhrle, J.; Schomburg, L.; Holleczek, B.; Brenner, H. Serum 25-hydroxyvitamin D and cancer risk in older adults. Results from a large German prospective cohort study. Cancer Epidemiol. Biomark. Prev. 2013, 22, 905-916.
19. Schöttker, B.; Saum, K. U.; Perna, L.; Ordóñez-Mena, J. M.; Holleczek, B.; Brenner, H. Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health? Eur. J. Epidemiol. 2014, 29, 199-210.
20. Schöttker, B.; Haug, U.; Schomburg, L.; Köhrle, J.; Perna, L.; Müller, H.; Holleczek, B.; Brenner, H. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am. J. Clin. Nutr. 2013, 97, 782-793.
21. Schöttker, B.; Jorde, R.; Peasey, A.; Thorand, B.; Jansen, E. H.; Groot, L.; Streppel, M.; Gardiner, J.; Ordóñez-Mena, J. M.; Perna, L.; et al. Vitamin D and mortality: Meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014, doi: 10. 1136/bmj. g3656.
22. Hutchinson, M. S.; Grimnes, G.; Joakimsen, R. M.; Figenschau, Y.; Jorde, R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromsø study. Eur. J. Endocrinol. 2010, 162, 935-942.
23. Thorand, B.; Kolb, H.; Baumert, J.; Koenig, W.; Chambless, L.; Meisinger, C.; Illig, T.; Martin, S.; Herder, C. Elevated levels of interleukin-18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005, 54, 2932-2938.
24. Van der Wielen, R. P.; Lowik, M. R.; van den Berg, H.; de Groot, L. C.; Haller, J.; Moreiras, O.; van Staveren, W. A. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346, 207-210.
25. Melamed, M. L.; Michos, E. D.; Post, W.; Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 2008, 168, 1629-1637.
26. Peasey, A.; Bobak, M.; Kubinova, R.; Malyutina, S.; Pajak, A.; Tamosiunas, A.; Pikhart, H.; Nicholson, A.; Marmot, M. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study. BMC Public Health 2006, 6, 255.
27. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Catharine, R., Taylor, C. L., Yaktine, A. L., Del Valle, H. B., Eds.; National Academies Press: Washington, DC, USA, 2011.
28. Maalmi, H.; Ordonez-Mena, J. M.; Schöttker, B.; Brenner, H. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies. Eur. J. Cancer 2014, 50, 1510-1521.
29. Walston, J.; Hadley, E. C.; Ferrucci, L.; Guralnik, J. M.; Newman, A. B.; Studenski, S. A.; Ershler, W. B.; Harris, T.; Fried, L. P. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J. Am. Geriatr. Soc. 2006, 54, 991-1001.
30. Mitnitski, A. B.; Mogilner, A. J.; Rockwood, K. Accumulation of deficits as a proxy measure of aging. Sci. World J. 2001, 1, 323-336.
31. Shamliyan, T.; Talley, K. M.; Ramakrishnan, R.; Kane, R. L. Association of frailty with survival: A systematic literature review. Ageing Res. Rev. 2012, 12, 719-736.
32. Idler, E. L.; Benyamini, Y. Self-rated health and mortality: A review of twenty-seven community studies. J. Health Soc. Behav. 1997, 38, 21-37.
33. Hirani, V.; Naganathan, V.; Cumming, R. G.; Blyth, F.; Le Couteur, D. G.; Handelsman, D. J.; Waite, L. M.; Seibel, M. J. Associations Between Frailty and Serum 25-Hydroxyvitamin D and 1, 25-Dihydroxyvitamin D Concentrations in Older Australian Men: The Concord Health and Ageing in Men Project. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 42, 352-359.
34. Engelsen, O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients 2010, 2, 482-495.
35. MacLaughlin, J.; Holick, M. F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Investig. 1985, 76, 1536-1538.
36. Wong, Y. Y.; McCaul, K. A.; Yeap, B. B.; Hankey, G. J.; Flicker, L. Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: The Health in Men Study. J. Clin. Endocrinol. Metab. 2013, 98, 3821-3828.
37. Smit, E.; Crespo, C. J.; Michael, Y.; Ramirez-Marrero, F. A.; Brodowicz, G. R.; Bartlett, S.; Andersen, R. E. The effect of vitamin D and frailty on mortality among non-institutionalized US older adults. Eur. J. Clin. Nutr. 2012, 66, 1024-1028.
38. Hill, A. B. The environment and disease: Association or causation? Proc. R. Soc. Med. 1965, 58, 295-300.
39. Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
40. Brewer, L. C.; Michos, E. D.; Reis, J. P. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr. Drug Targets 2011, 12, 54-60.
41. Forman, J. P.; Williams, J. S.; Fisher, N. D. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010, 55, 1283-1288.
42. Krishnan, A. V.; Trump, D. L.; Johnson, C. S.; Feldman, D. The role of vitamin D in cancer prevention and treatment. Endocrinol. Metab. Clin. N. Am. 2010, 39, 401-418.
43. Wolden-Kirk, H.; Overbergh, L.; Christesen, H. T.; Brusgaard, K.; Mathieu, C. Vitamin D and diabetes: Its importance for beta cell and immune function. Mol. Cell. Endocrinol. 2011, 347, 106-120.
44. Herr, C.; Greulich, T.; Koczulla, R. A.; Meyer, S.; Zakharkina, T.; Branscheidt, M.; Eschmann, R.; Bals, R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir. Res. 2011, 12, 31.
45. Di Rosa, M.; Malaguarnera, M.; Nicoletti, F.; Malaguarnera, L. Vitamin D3: A helpful immuno-modulator. Immunology 2011, 134, 123-139.
46. Skaaby, T.; Husemoen, L. L.; Pisinger, C.; Jorgensen, T.; Thuesen, B. H.; Fenger, M.; Linneberg, A. Vitamin D status and cause-specific mortality: A general population study. PLoS ONE 2012, 7, e52423.
47. Bird, A. The epistemological function of Hill's criteria. Prev. Med. 2011, 53, 242-245.
48. Bjelakovic, G.; Gluud, L. L.; Nikolova, D.; Whitfield, K.; Wetterslev, J.; Simonetti, R. G.; Bjelakovic, M.; Gluud, C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2014, 1, doi: 10. 1002/14651858. CD007470. pub3.
49. Chowdhury, R.; Kunutsor, S.; Vitezova, A.; Oliver-Williams, C.; Chowdhury, S.; Kiefte-de-Jong, J. C.; Khan, H.; Baena, C. P.; Prabhakaran, D.; Hoshen, M. B.; et al. Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014, 348, g1903.
50. Kupferschmidt, K. Uncertain verdict as vitamin D goes on trial. Science 2012, 337, 1476-1478.
51. Bjelakovic, G.; Nikolova, D.; Gluud, L. L.; Simonetti, R. G.; Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 3, CD007176.
52. Murray, C. J.; Lopez, A. D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349, 1436-1442.
53. Weyland, P. G.; Grant, W. B.; Howie-Esquivel, J. Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality. Nutrients 2014, 6, 3403-3430.
54. Grant, W. B. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality. Dermatoendocrinology 2009, 1, 17-24.
55. Robsahm, T. E.; Schwartz, G. G.; Tretli, S. The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation. Cancers 2013, 5, 1439-1455.
56. White, J. H. Vitamin D metabolism and signaling in the immune system. Rev. Endocr. Metab. Disord. 2012, 13, 21-29.
57. Saggese, G.; Federico, G.; Balestri, M.; Toniolo, A. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J. Endocrinol. Investig. 1989, 12, 329-335.
58. Laird, E.; McNulty, H.; Ward, M.; Hoey, L.; McSorley, E.; Wallace, J. M.; Carson, E.; Molloy, A. M.; Healy, M.; Casey, M. C.; et al. Vitamin D deficiency is associated with inflammation in older irish adults. J. Clin. Endocrinol. Metab. 2014, 99, 1807-1815.
59. Cannell, J. J.; Grant, W. B.; Holick, M. F. Vitamin D and inflammation. Dermatoendocrinology 2014, 6, e983401.
60. Koller, L.; Kleber, M.; Goliasch, G.; Sulzgruber, P.; Scharnagl, H.; Silbernagel, G.; Grammer, T.; Delgado, G.; Tomaschitz, A.; Pilz, S.; et al. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur. J. Heart Fail. 2014, 16, 758-766.
61. Naess, H.; Nyland, H.; Idicula, T.; Waje-Andreassen, U. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J. Stroke Cerebrovasc. Dis. 2013, 22, e435-e440.
62. Villasenor, A.; Flatt, S. W.; Marinac, C.; Natarajan, L.; Pierce, J. P.; Patterson, R. E. Postdiagnosis C-reactive protein and breast cancer survivorship: Findings from the WHEL study. Cancer Epidemiol. Biomark. Prev. 2014, 23, 189-199.
63. Cooney, R. V.; Chai, W.; Franke, A. A.; Wilkens, L. R.; Kolonel, L. N.; Le, M. L. C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients. Cancer Epidemiol. Biomark. Prev. 2013, 22, 1278-1288.
64. Grant, W. B.; Juzeniene, A.; Moan, J. E. Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries. Scand. J. Public Health 2011, 39, 70-78.
65. Schöttker, B.; Ball, D.; Gellert, C.; Brenner, H. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res. Rev. 2013, 12, 708-718.
66. O'Donnell, S.; Cranney, A.; Horsley, T.; Weiler, H. A.; Atkinson, S. A.; Hanley, D. A.; Ooi, D. S.; Ward, L.; Barrowman, N.; Fang, M.; et al. Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: Systematic review. Am. J. Clin. Nutr. 2008, 88, 1528-1534.
67. Reichrath, J.; Nurnberg, B. Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinology 2009, 1, 253-261.
68. Adami, P. E.; Negro, A.; Lala, N.; Martelletti, P. The role of physical activity in the prevention and treatment of chronic diseases. Clin. Ther. 2010, 161, 537-541.
69. Jorde, R.; Sneve, M.; Hutchinson, M.; Emaus, N.; Figenschau, Y.; Grimnes, G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 2010, 171, 903-908.
70. Hathcock, J. N.; Shao, A.; Vieth, R.; Heaney, R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85, 6-18.
71. Slomski, A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011, 305, 453-456.
72. Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P.; Murad, M. H.; Weaver, C. M. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930.